Biological Polymerase Chain Reaction (PCR) Technology Market Report 2026

Biological Polymerase Chain Reaction (PCR) Technology Market Overview

• Biological Polymerase Chain Reaction (PCR) Technology market size has reached to $16.62 billion in 2025 • Expected to grow to $26.69 billion in 2030 at a compound annual growth rate (CAGR) of 9.9% • Growth Driver: Rising Incidence Of Infectious Diseases Fueling The Growth Of The Market Due To Increasing Global Travel And Pathogen Spread • Market Trend: Advancements In Digital PCR Assay Kits For Precise DNA And RNA Quantification • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Biological Polymerase Chain Reaction (PCR) Technology Market?

Biological polymerase chain reaction (PCR) technology is a laboratory method used to create multiple copies of a specific DNA segment from a minimal starting amount. It works through repeated temperature changes that separate DNA strands, allow short primer sequences to bind, and enable enzymes to synthesize new DNA strands. This cyclical process rapidly produces a large quantity of the target DNA with high precision and accuracy, making it an essential technique for studying genetic material. The main product types of biological polymerase chain reaction (PCR) technology include reagents, consumables, and software and services. Reagents refer to chemical substances used in PCR reactions to detect, amplify, or quantify DNA or RNA. It uses multiple techniques such as real-time polymerase chain reaction (PCR), conventional polymerase chain reaction (PCR), digital polymerase chain reaction (PCR), reverse transcription polymerase chain reaction (PCR), hot-start polymerase chain reaction (PCR), multiplex polymerase chain reaction (PCR), and others, and is applied for diagnostic applications, genotyping, nucleic acid detection, gene expression analysis, nucleic acid synthesis, genetic sequencing, environmental applications, standard validation or verification, and others. It caters to several end users, such as hospital laboratories, diagnostic laboratories, academic and government organizations, pharma-biotech companies, and others.

What Is The Biological Polymerase Chain Reaction (PCR) Technology Market Growth Forecast?

The biological polymerase chain reaction (pcr) technology market size is expected to see strong growth in the next few years. It will grow to $26.69 billion in 2030 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to growing adoption of point-of-care pcr systems, increasing use of pcr in oncology and genetic testing, expansion of personalized medicine, rising investments in laboratory automation, increasing demand for rapid diagnostic solutions. Major trends in the forecast period include increasing adoption of real-time and digital pcr techniques, rising demand for high-sensitivity molecular diagnostics, growing integration of pcr data analysis software, expansion of multiplex and high-throughput pcr applications, enhanced focus on workflow automation.

Global Biological Polymerase Chain Reaction (PCR) Technology Market Segmentation

1) By Product Type: Reagents, Consumables, Software And Services 2) By Technique: Real-Time Polymerase Chain Reaction (PCR), Conventional Polymerase Chain Reaction (PCR), Digital Polymerase Chain Reaction (PCR), Reverse Transcription Polymerase Chain Reaction (PCR), Hot-Start Polymerase Chain Reaction (PCR), Multiplex Polymerase Chain Reaction (PCR), Other Polymerase Chain Reaction (PCR) Techniques 3) By Application: Diagnostic Applications, Genotyping, Nucleic Acid Detection, Gene Expression Analysis, Nucleic Acid Synthesis, Genetic Sequencing, Environmental Applications, Standard Validation Or Verification, Other Applications 4) By End User: Hospital Laboratories, Diagnostic Laboratories, Academic And Government Organizations, Pharma-Biotech Companies, Other End Users Subsegments: 1) By Reagents: DNA Polymerase, DNTPs, Primers And Probes, Buffers And Master Mixes, Enzymes, Nucleic Acid Templates, Additives And Enhancers 2) By Consumables: PCR Tubes, PCR Plates, Sealing Films And Mats, Microplates, Reaction Vessels, Pipette Tips, PCR Strips 3) By Software And Services: PCR Data Analysis Software, Real-Time PCR Analysis Software, Cloud-Based Data Storage Solutions, PCR Workflow Management Tools, Technical Support Services, Calibration And Maintenance Services, Training And Consultation Services

What Is The Driver Of The Biological Polymerase Chain Reaction (PCR) Technology Market?

The rising incidence of infectious diseases is expected to propel the growth of the biological polymerase chain reaction (PCR) technology market going forward. Infectious diseases are illnesses caused by bacteria, viruses, fungi, or parasites. Infectious diseases refer to disorders caused by organisms such as bacteria, viruses, fungi, or parasites. The rising incidence of infectious diseases is driven by increasing global travel, which facilitates faster and wider spread of pathogens across regions. Biological polymerase chain reaction (PCR) technology helps combat infectious diseases by enabling rapid and accurate detection of pathogens, allowing for early diagnosis, timely treatment, and effective outbreak control. For instance, in December 2024, according to the World Health Organization, a Switzerland-based intergovernmental agency, in 2023, malaria, a major infectious disease, caused an estimated 263 million cases globally, up approximately 252 million from 2022, with a case incidence of 60.4 per 1,000 population at risk, up from 58.6 in 2022, 597,000 deaths, and 94 percent of cases and 95 percent of deaths occurring in the WHO African Region. Therefore, the rising incidence of infectious diseases is driving the growth of the biological polymerase chain reaction (PCR) technology industry.

Key Players In The Global Biological Polymerase Chain Reaction (PCR) Technology Market

Major companies operating in the biological polymerase chain reaction (pcr) technology market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Agilent Technologies Inc., Revvity Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Eppendorf AG, Cepheid Inc., Bio-Techne Corporation, GenScript Biotech Corporation, Takara Bio Inc., Promega Corporation, Analytik Jena GmbH+Co. KG, New England Biolabs Inc., Enzo Biochem Inc., LGC Biosearch Technologies Inc., Bioline Reagents Ltd., Illumina Inc., Abbott Laboratories

Global Biological Polymerase Chain Reaction (PCR) Technology Market Trends and Insights

Major companies operating in the biological polymerase chain reaction (PCR) technology market are focusing on technological advancement, such as digital PCR assay kits to enable precise and efficient quantification of DNA and RNA for biopharma research, cell and gene therapies, and food safety. Digital PCR assay kits refer to laboratory reagent kits used to perform highly sensitive and precise DNA or RNA quantification using digital PCR technology. For instance, in November 2023, QIAGEN, a Netherlands-based provider of molecular biology solutions, launched the QIAcuity Digital PCR Kits and updated QIAcuity software to expand applications in biopharma and food-safety testing. These kits use optimized reagents and consumables to partition nucleic acid samples into thousands of nanoliter-scale reactions, enabling sensitive detection and quantification of rare variants or pathogens. The updated software provides automated analysis, workflow guidance, and data visualization for easier interpretation. Key features include high sensitivity, broad dynamic range, multiplexing capability, and user-friendly operation. Applications cover gene expression analysis, mutation detection, microbial testing, and quality control, offering increased accuracy, reduced hands-on time, and reliable low-copy detection across research and regulatory settings.

What Are Latest Mergers And Acquisitions In The Biological Polymerase Chain Reaction (PCR) Technology Market?

In July 2025, Bio-Rad Laboratories Inc., a US-based life science research and clinical diagnostics company, acquired Stilla Technologies SA for an undisclosed amount. With this acquisition, Bio-Rad aims to strengthen its position in the digital PCR market and expand its molecular diagnostics capabilities through Stilla’s advanced crystal digital PCR technology. Stilla Technologies SA is a France-based provider of biological polymerase chain reaction (PCR) technology.

Regional Outlook

North America was the largest region in the biological polymerase chain reaction (PCR) technology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Biological Polymerase Chain Reaction (PCR) Technology Market?

The biological polymerase chain reaction (PCR) technology market consists of revenues earned by entities by providing services such as DNA amplification, genetic testing, and pathogen detection. The market value includes the value of related goods sold by the service provider or included within the service offering. The biological polymerase chain reaction (PCR) technology market also includes sales of enzymes, primers, probes, and thermal cyclers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Biological Polymerase Chain Reaction (PCR) Technology Market Report 2026?

The biological polymerase chain reaction (pcr) technology market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the biological polymerase chain reaction (pcr) technology industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.